KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Change in Intangibles (2020 - 2024)

Recursion Pharmaceuticals' Change in Intangibles history spans 4 years, with the latest figure at $350000.0 for Q4 2024.

  • For Q4 2024, Change in Intangibles changed 0.0% year-over-year to $350000.0; the TTM value through Dec 2025 reached $350000.0, down 89.55%, while the annual FY2025 figure was $2.2 million, 35.58% down from the prior year.
  • Change in Intangibles reached $350000.0 in Q4 2024 per RXRX's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $3.0 million in Q2 2024 to a low of $82000.0 in Q3 2023.
  • Average Change in Intangibles over 4 years is $735857.1, with a median of $350000.0 recorded in 2023.
  • Peak YoY movement for Change in Intangibles: crashed 72.67% in 2023, then changed 0.0% in 2024.
  • A 4-year view of Change in Intangibles shows it stood at $904000.0 in 2020, then tumbled by 66.81% to $300000.0 in 2022, then increased by 16.67% to $350000.0 in 2023, then changed by 0.0% to $350000.0 in 2024.
  • Per Business Quant, the three most recent readings for RXRX's Change in Intangibles are $350000.0 (Q4 2024), $3.0 million (Q2 2024), and $350000.0 (Q4 2023).